Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu ... MarketWatch (press release) DEERFIELD, Ill., Mar 11, 2010 (BUSINESS WIRE) -- Baxter International Inc. (NYSE:BAX) , in conjunction with DynPort Vaccine Company LLC (DVC), a CSC Company ... |
Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu … – MarketWatch (press release)
Posted in Flu.
0 Responses
Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.